McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies ...

Thousands of apartments have been added — and hundreds taken away — from Greater Philadelphia's pipeline in recent weeks, ...

Wave Life Sciences (WVE) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to earnings of $0.07 per share a year ago. These ...

Watertown, Mass., added millions of square feet of lab space in just a few years. Here's how it happened, and why the pace ...

The campaign we have all just gone through has not been very focused on a lot of policy detail," said Buchanan Ingersoll & ...

Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is ...

Enveric Biosciences licenses its EB-002 drug candidate to MycoMedica Life Sciences, focusing on mental health treatment ...

Goodwin is presenting a two-part publication series covering life sciences trends involving license deals, M&A, and financing for Greater China’s ...

Roth MKM analyst Jason Wittes initiated coverage of TriSalus Life Sciences (TLSI) with a Buy rating and $11 price target The company’s ...

Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...

It is now imperative for life science companies to optimize Regulatory Affairs resources using next-generation technology if they are to ensure affordable patient access to treatments and achieve ...

"We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," said Dr. Chris Mansi, CEO and co-founder at Viz.ai. “For many with HCM, the path to diagnosis and ...